Stock option expensing

iSIGN Media Announces A Promissory Note Extension and Related Interest Terms

Retrieved on: 
Saturday, June 6, 2020
Options, Equity securities, Money, Finance, Economy, Corporate finance, Warrant, Covered warrant, Stock option expensing

The Note matured on January 31, 2020 and the parties have agreed to an extension of the due date to June 30, 2021.

Key Points: 
  • The Note matured on January 31, 2020 and the parties have agreed to an extension of the due date to June 30, 2021.
  • Additionally, the parties have agreed that the interest on the additional term will be by way of a warrant bonus, with the number of warrants being 12,014,000.
  • Calculation of the number of warrants is based on the $600,700 value of the Note and the warrant exercise price of $0.05.
  • The warrants will have a term that matches the due date of the Note, June 30, 2021 and cannot be extended.

Roth CH Acquisition I Co. Announces the Separate Trading of its Common Stock and Warrants, Commencing June 11, 2020

Retrieved on: 
Thursday, June 4, 2020
Banking, Professional services, Finance, Finance, Financial markets, Money, Equity securities, Corporate finance, Stock market, Options, Warrant, NASDAQ, Stock, Stock option expensing

No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Key Points: 
  • No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
  • The shares of common stock and warrants that are separated will trade on the Nasdaq Capital Market under the symbols ROCH and ROCHW, respectively.
  • Those units not separated will continue to trade on the Nasdaq Capital Market under the symbol ROCHU.
  • Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Companys transfer agent, in order to separate the units into shares of common stock and warrants.

TransGlobe Energy Corporation Announces Director/PDMR Shareholdings

Retrieved on: 
Tuesday, May 26, 2020
Finance, Stock market, Money, Equity securities, Economy, Options, Labour law, Property law, Vesting, Share, Phantom stock, Stock option expensing

The DSUs were issued in accordance with the Deferred Share Unit Plan of the Company.

Key Points: 
  • The DSUs were issued in accordance with the Deferred Share Unit Plan of the Company.
  • No shares will be issued upon retirement or vesting of any of the share units as the instruments are settled in cash.
  • The Company has also issued Performance Share Units (PSUs) on May 22, 2020 to the PDMRs in accordance with the Performance Share Unit Plan of the Company.
  • No shares will be issued upon exercise or vesting of any of the share units as the instruments are settled in cash.

OptionTrax® Widens the Lead in Stock-Based Compensation Reporting for Equity Award Plans

Retrieved on: 
Tuesday, May 12, 2020
Financial economics, Financial markets, Corporate finance, Options, Stock market, Employee stock option, Equity, Accounting, International Financial Reporting Standards, Financial statement, Stock option expensing, Executive compensation in the United States

The financial reporting includes calculations for any performance award payouts, from 0% to over 100%, as well as hedging to smooth company stock-based compensation expense.

Key Points: 
  • The financial reporting includes calculations for any performance award payouts, from 0% to over 100%, as well as hedging to smooth company stock-based compensation expense.
  • Unlike other equity compensation platforms, OptionTrax handles multiple performance metrics on a single grant without requiring the company to split the award until multiple pieces.
  • The latest OptionTrax release also includes stock-based compensation reporting for non-USD cash-settled equity award plans.
  • Per Elena Thomas "OptionTrax has long helped clients manage stock-based compensation liability accounting for awards under GAAP and equity accounting for plans under IFRS2.

American BriVision Announces Two Financial Transactions to Improve Working Capital and Reduce Debt

Retrieved on: 
Monday, April 13, 2020
Financial markets, Finance, Corporate finance, Financial economics, Equity securities, Stock market, Options, Warrant, Stock, Common stock, Stock dilution, Stock option expensing

Pursuant to the agreements, the holders have exchanged their notes at an exchange price of $1.84 per share for 506,297 shares of ABVC common stock.

Key Points: 
  • Pursuant to the agreements, the holders have exchanged their notes at an exchange price of $1.84 per share for 506,297 shares of ABVC common stock.
  • Additionally, the holders received three-year warrants to purchase 506,297 shares of ABVC common stock at an initial exercise price of $5.00 per share.
  • Each investor will also receive a five-year warrant at an initial exercise price of $6.00 per share for each share of ABVC common stock purchased.
  • Upon the closing of both transactions, the total number of outstanding ABVC common shares will increase to 20,438,910 from 19,488,168.

Virgin Galactic Announces Redemption of Public Warrants

Retrieved on: 
Friday, March 13, 2020
Aerospace, Manufacturing, Air, Transport, Engineering, Options, Equity securities, Corporate finance, Money, Finance, Warrant, Economy, Stock option expensing, Covered warrant

At the direction of the Company, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Public Warrants.

Key Points: 
  • At the direction of the Company, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Public Warrants.
  • Accordingly, holders may no longer exercise Public Warrants and receive Common Stock in exchange for payment in cash of the $11.50 per warrant exercise price.
  • Accordingly, by virtue of the cashless exercise of the Public Warrants, exercising warrant holders will receive 0.5073 of a share of Common Stock for each Public Warrant surrendered for exercise.
  • Any Public Warrants (including Public Warrants that are included in outstanding units) that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be delisted, void and no longer exercisable, and the holders will have no rights with respect to those Public Warrants, except to receive the Redemption Price (or as otherwise described in the redemption notice for holders who hold their Public Warrants in street name).

BiondVax Announces Warrant Agreement Amendment to Permit Holders of Warrants to Exercise Both on a Cash and Cashless Basis

Retrieved on: 
Thursday, January 16, 2020
Options, Equity securities, Finance, Money, Financial economics, Warrant, Exercise, American depositary receipt, Stock option expensing, Covered warrant

Warrant holders will continue to be able to exercise their Warrants on a cash basis as well.

Key Points: 
  • Warrant holders will continue to be able to exercise their Warrants on a cash basis as well.
  • The cashless exercise right being offered to Warrant holders allows them to capture the value between the current price of BiondVax's American Depositary Shares ("ADSs") and the exercise price of the warrants without the need to provide cash on exercise.
  • Cashless exercise would enable Warrant holders to exercise their Warrants without paying cash but rather paying the exercise price from the value of the ADSs of BiondVax that would otherwise be issued to the Warrant holder were the Warrants exercised on a cash basis.
  • The Warrant holders exercising on a cashless basis would receive a number of ADSs equal in value to the market value of one ADS at the time of exercise (calculated according to a formula in the amendment to warrant agreement) less the exercise price of the warrants multiplied by the number of Warrants being exercised.

Emerging Markets Report: First and Foremost

Retrieved on: 
Thursday, December 12, 2019
Corporate finance, Financial economics, Finance, Money, Equity securities, Stock market, Options, Warrant, Stock, Restricted stock, Stock option expensing

Now, the Company can fairly argue that they can be first to approval and market- in a significant opportunity and that they are surrounding themselves with some of the foremost names in the Life Science industry.

Key Points: 
  • Now, the Company can fairly argue that they can be first to approval and market- in a significant opportunity and that they are surrounding themselves with some of the foremost names in the Life Science industry.
  • cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration.
  • In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.
  • EMC has been paid $15,000 plus 15,000 restricted shares on behalf of NeuroOne Medical Technologies Corporation for various marketing services including this report.

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Friday, November 15, 2019
Options, Finance, Corporate finance, Money, Stock market, Financial economics, Equity securities, Contract law, Stock, Exercise, Stock option expensing, Employee stock option

The equity award was approved onSeptember 20, 2019, in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The equity award was approved onSeptember 20, 2019, in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The employee received an option to purchase 80,224 shares of Apellis common stock.
  • The option has an exercise price of$29.03per share, which is equal to the closing price of Apellis common stock onNovember 11, 2019, the grant date of the option.
  • Apellis is the first company to advance chronic therapy with a C3 inhibitor into clinical trials.

Experience Investment Corp. Announces the Separate Trading of its Class A Common Stock and Warrants

Retrieved on: 
Wednesday, October 30, 2019
Finance, Money, Financial markets, Equity securities, Corporate finance, Stock market, Options, Warrant, NASDAQ, Stock, Stock option expensing, Ticker symbol

ClassA common stock and warrants that are separated will trade on The Nasdaq Capital Market under the symbols EXPC and EXPCW, respectively.

Key Points: 
  • ClassA common stock and warrants that are separated will trade on The Nasdaq Capital Market under the symbols EXPC and EXPCW, respectively.
  • No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
  • Those units not separated will continue to trade on The Nasdaq Capital Market under the symbol EXPCU.
  • Holders of units will need to have their brokers contact American Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into shares of Class A common stock and warrants.